why choose us

First received: July 08, 2024

Clinical Trial: Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Renal Impairment

Study Type: INTERVENTIONAL


Official Title: Phase 1, Open-Label, Non-Randomized, Single-Center, Single-Dose Study to Assess the Pharmacokinetics & Safety of ANT3310 Combined With Meropenem Administered as a Single Intravenous Infusion to Ad

Brief Summary: This is an open-label, non-randomized, single-center, single i.v.dose Phase 1 trial to evaluate the pharmacokinetics and safety of a combination of ANT3310 and meropenem in participants with different degrees of renal function impairment, including participants with End-Stage Renal Disease (ESRD), compared with matching control participants with normal renal function.

Read more